Medtronic Announces FDA Approval and Market Availability of Sprint Quattro Secure S Single Coil Defibrillation Lead
Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval of the Medtronic Sprint Quattro Secure S single coil defibrillation lead (Model 6935) for use with implantable defibrillators in patients at risk for dangerous tachyarrhythmias (fast heartbeats) and sudden cardiac arrest. This new defibrillation lead is an addition to the Sprint Quattro family that is supported by more than seven years of post-market performance data. It provides an option for physicians who prefer a specific type of lead for patients with unique anatomies and is designed to help reduce tip pressure. The U.S. approval and market release of this single coil option follows its recent European approval and launch. [more...]
|
|
|
